Six actives. Each with a purpose.

It supports calcium and potassium movement across cell membranes, important for nerve signals and muscle contraction. Magnesium also participates in ATP-related reactions: ATP is the energy-carrying molecule cells use.

Calcium signalling helps control muscle contraction. Researchers have explored magnesium’s interaction with calcium and prostaglandins, including PGF2α, in menstrual-comfort studies. These proposed pathways sit alongside clinical symptom measurements. Digestive tolerance varies with the form, quantity and person; the research uses specified preparations.

Its structure resembles glutamate, a brain-signalling molecule. Receptor interactions are a proposed mechanism, informed by experimental research; the human trial assessed symptoms and cognitive tests.

The Hidese trial focused on stress and sleep measures in healthy adults. This provides context for the mental side of wellbeing, with pain experience an indirect theme. Proposed brain-signalling mechanisms involve glutamate receptors; experimental pathways and clinical symptom measurements are different levels of research.

In a laboratory enzyme study, isolated 10-gingerol and two shogaols inhibited COX-2, an enzyme involved in prostaglandin production. This was experimental compound research, distinct from the clinical trial of ginger root powder.

Laboratory research explores gingerols and shogaols in COX and LOX pathways involved in inflammatory signalling. A 2009 trial compared 1 g/day root powder with mefenamic acid and ibuprofen for three days. Separate clinical research studied a particular extract for pregnancy-related nausea, a different population and use.

The perimenopause trial tracked symptom scales and blood hormone measures over eight weeks. Researchers discuss possible estrogen-related and stress-response pathways; understanding the precise mechanisms remains an active area of study.

The 2013 review describes shatavarins, a group of steroidal saponins, and findings from isolated-tissue and animal experiments, including uterine contractility. More recent placebo-controlled trials used specified root extracts and measured symptoms, perceived stress, sleep or quality of life in peri/menopausal populations: distinct research settings with different questions.

Zinc contributes to hundreds of enzymes, immune-cell activity and cell signalling. Nutritional amounts refer to elemental zinc; that is different from the weight of zinc gluconate or zinc sulphate.

Researchers discuss prostaglandin-related and antioxidant pathways as possible explanations for zinc’s menstrual-comfort findings. The 2023 trial measured pain, nausea and vomiting, and use of extra pain medicine. Its results concern pain experience; menstrual blood loss was not an outcome. Compound weight and elemental zinc are also distinct quantities.

An active form called PLP helps enzymes build neurotransmitters and participates in hormone action. EFSA’s assessment describes B6’s role in regulating hormonal activity as normal nutritional physiology.

B6’s active coenzyme forms help enzymes produce serotonin, dopamine and GABA. PMS trials have studied B6 alone or with magnesium at specified supplement quantities, measuring symptom scores across menstrual cycles. These studies sit alongside B6’s established physiological roles in hormone action, metabolism and the nervous system.